Last reviewed · How we verify

NCT05816512: GNPG

Antimicrobial Efficacy of Biogenic Gold Nano Particle From Pelargonium Graveolens Leaves Extract Mouthwash for Children

Status unknown NA Last updated 18 April 2023
What this trial tests

NA trial testing Gold Nano particle from Pelargonium Graveolens Mouthwash in Dental Caries in 60 participants. Status unknown.

Timeline
1 April 2023
Primary endpoint
20 September 2023
20 March 2024

Quick facts

Lead sponsorAhmed Yousif Mahdi
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment60
Start date1 April 2023
Primary completion20 September 2023
Estimated completion20 March 2024
Sites1 location across Iraq

Drugs / interventions tested

Conditions studied

Sponsor

Ahmed Yousif Mahdi — full company profile →

Who can join

Adults 7 to 14, male only, with Dental Caries or Gingivitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is randomized controlled trial ... The null hypothesis of the present study is that there is no antibacterial efficacy of gold nanoparticles of pelargonium graveolens mouthwash against Streptococcus mutans and Candida Albicans . Meanwhile the alternative hypothesis of the present study is that gold nanoparticles of pelargonium graveolens mouthwash have antimicrobial activity against Streptococcus mutans and Candida Albicans .

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Gold nanostructures in melanoma: Advances in treatment, diagnosis, and theranostic applications.
    Dastgheib ZS, Abolmaali SS, Farahavar G, Salmanpour M, et al · · 2024 · cited 14× · PMID 39170173 · DOI 10.1016/j.heliyon.2024.e35655
  2. Harnessing Nature's Toolbox: Naturally Derived Bioactive Compounds in Nanotechnology Enhanced Formulations.
    Sanjai C, Gaonkar SL, Hakkimane SS. · · 2024 · cited 10× · PMID 39494011 · DOI 10.1021/acsomega.4c07756
  3. Medical importance and pharmacokinetics of gold nanoparticles in the human body.
    Singh P, Joshi AS, Singh H, Mijakovic I. · · 2025 · cited 8× · PMID 41068777 · DOI 10.1186/s12943-025-02418-3
  4. Phytonanotherapy for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Nendouvhada LP, Sibuyi NRS, Fadaka AO, Meyer S, et al · · 2024 · cited 5× · PMID 38891759 · DOI 10.3390/ijms25115571
  5. Antimicrobial Efficacy of Pelargonium Graveolens Gold Nanoparticles: A Novel Mouthwash for Children.
    Asker AYM, Al Haidar AHMJ. · · 2026 · PMID 42036760 · DOI 10.1111/idh.70071

Verify or expand the search:

Other recruiting trials for Dental Caries

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05816512.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing